Casdin Capital, LLC has filed its 13F form on October 18, 2024 for Q2 2024 where it was disclosed a total value porftolio of $1.16 Billion distributed in 38 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Biolife Solutions Inc with a value of $187M, Revolution Medicines, Inc. with a value of $171M, Sarepta Therapeutics, Inc. with a value of $170M, Standard Biotools Inc. with a value of $113M, and Avidity Biosciences, Inc. with a value of $85.2M.
Examining the 13F form we can see an increase of $5.06M in the current position value, from $1.15B to 1.16B.
Casdin Capital, LLC is based out at New York, NY
Below you can find more details about Casdin Capital, LLC portfolio as well as his latest detailed transactions.